Roger D. Tung
2013
In 2013, Roger D. Tung earned a total compensation of $593.6K as President and Chief Executive Officer at Concert Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $212,211 |
|---|---|
| Salary | $373,171 |
| Other | $8,178 |
| Total | $593,560 |
Tung received $373.2K in salary, accounting for 63% of the total pay in 2013.
Tung also received $212.2K in non-equity incentive plan and $8.2K in other compensation.
Rankings
In 2013, Roger D. Tung's compensation ranked 8,756th out of 12,286 executives tracked by ExecPay. In other words, Tung earned more than 28.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,756 out of 12,286 | 29th |
Division Manufacturing | 3,189 out of 4,612 | 31st |
Major group Chemicals And Allied Products | 1,011 out of 1,462 | 31st |
Industry group Drugs | 770 out of 1,156 | 33rd |
Industry Pharmaceutical Preparations | 610 out of 890 | 32nd |
Source: SEC filing on April 20, 2015.
Tung's colleagues
We found one more compensation record of an executive who worked with Roger D. Tung at Concert Pharmaceuticals in 2013.
2013
Nancy Stuart
Concert Pharmaceuticals
Chief Operating Officer
News
Concert Pharmaceuticals CEO Roger Tung's 2021 pay rises 17% to $3.5M
April 26, 2022
Concert Pharmaceuticals CEO Roger Tung's 2020 pay rises 9% to $3M
April 27, 2021
Concert Pharmaceuticals CEO Roger Tung's 2019 pay falls 40% to $2.8M
April 28, 2020
Concert Pharmaceuticals CEO Roger Tung's 2018 pay jumps 34% to $4.6M
April 29, 2019